Wed, May 3, 2023
Tue, May 2, 2023
Mon, May 1, 2023

Patrick Dolezal Maintained (AVDL) at Buy with Increased Target to $26 on, May 2nd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-26-on-may-2nd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Patrick Dolezal of LifeSci Capital, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Buy with Increased Target from $17 to $26 on, May 2nd, 2023.

Patrick, nor any peers, have made any analyst calls on AVDL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources